Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
328
-
Total 13F shares, excl. options
-
103M
-
Shares change
-
+103M
-
Total reported value, excl. options
-
$6.39B
-
Value change
-
+$6.39B
-
Put/Call ratio
-
1.29
-
Number of buys
-
310
-
Price
-
$61.93
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2015
360 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q4 2015.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 328 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103M shares
of 159M outstanding shares and own 65.16% of the company stock.
Largest 10 shareholders include FMR LLC (17.7M shares), Clearbridge Investments, LLC (9.47M shares), VANGUARD GROUP INC (8.25M shares), BAILLIE GIFFORD & CO (8.08M shares), BB BIOTECH AG (6.53M shares), WADDELL & REED FINANCIAL INC (5.77M shares), BlackRock Institutional Trust Company, N.A. (3.01M shares), STATE STREET CORP (2.62M shares), BlackRock Fund Advisors (2.6M shares), and FIRST TRUST ADVISORS LP (2.33M shares).
This table shows the top 328 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.